{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2000-N-0163\" sorted by posted_date descending", "rows": [["FDA-2000-N-0163-0023", "FDA", "FDA-2000-N-0163", "Reclassifications of Category IIIA Biological Products, Bacterial Vaccines and Related Biological Products, etc.: Delmont Laboratories, Inc.; Denial of Request for Hearing and Revocation of License", "Notice", "NFR-Notice of Final Rule", "2010-12-06T05:00:00Z", 2010, 12, "2010-12-06T05:00:00Z", null, "2010-12-06T17:22:07Z", "2010-30441", 0, 0, "0900006480bafeaf"], ["FDA-2000-N-0163-0022", "FDA", "FDA-2000-N-0163", "Tab G - \"Bacterial Vaccines and Bacterial Antigens with No U.S. Standard of Potency, dated October 27, 1978\" - [Covington & Burling [Delmont Laboratories, Inc.] - Supplement Appearance Request] re: FDA-2000-N-0163-0018", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2009-09-22T04:00:00Z", 2009, 9, null, null, "2009-09-22T19:06:00Z", null, 0, 0, "09000064804d1a2f"], ["FDA-2000-N-0163-0010", "FDA", "FDA-2000-N-0163", "Tab 2 - \"License Revocation Letter to BioPort Corporation,\" dated November 20, 2000 - [Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice] - Background re: FDA-2000-N-0163-0002", "Supporting & Related Material", "BKG-Background Material", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T14:48:08Z", null, 0, 0, "09000064804d1a1b"], ["FDA-2000-N-0163-0021", "FDA", "FDA-2000-N-0163", "Tab C - \"Delmont Comments of January 8, 1978 (Docket No. 77N-0091), w/attachments\" - [Covington & Burling [Delmont Laboratories, Inc.] - Supplement Appearance Request] re: FDA-2000-N-0163-0018", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T21:03:48Z", null, 0, 0, "09000064804d1a39"], ["FDA-2000-N-0163-0015", "FDA", "FDA-2000-N-0163", "Tab B - \"FDA/CBER Response to Delmont Laboratories, Inc., dated October 12, 1993\" - [Delmont Laboratories, Inc. - Comment] re: FDA-2000-N-0163-0013", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T18:56:41Z", null, 0, 0, "09000064804d1a0a"], ["FDA-2000-N-0163-0014", "FDA", "FDA-2000-N-0163", "Tab A - \"Bacterial Vaccines and Bacterial Antigens with No U.S. Standard of Potency: Revocation of Licenses and Reclassification\" - [Delmont Laboratories, Inc. - Comment] re: FDA-2000-N-0163-0013", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T18:51:09Z", null, 0, 0, "09000064804d1a0f"], ["FDA-2000-N-0163-0016", "FDA", "FDA-2000-N-0163", "Tab D - \"Minutes and Attendance List from Meeting between Delmont Laboratories, Inc., and FDA/CBER\" - [Delmont Laboratories, Inc. - Comment] re: FDA-2000-N-0163-0013", "Supporting & Related Material", "C-Comment (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T19:49:06Z", null, 0, 0, "09000064804d1a14"], ["FDA-2000-N-0163-0019", "FDA", "FDA-2000-N-0163", "Tab A - \"Table of Attachments\" - [Covington & Burling [Delmont Laboratories, Inc.] - Supplement Appearance Request ] re: FDA-2000-N-0163-0018", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T20:55:10Z", null, 0, 0, "09000064804d1a3f"], ["FDA-2000-N-0163-0017", "FDA", "FDA-2000-N-0163", "Delmont Laboratories, Inc. - Appearance Request", "Other", "APE-Appearance Request", "2009-09-17T04:00:00Z", 2009, 9, "2009-09-17T04:00:00Z", null, "2013-07-27T21:05:57Z", null, 0, 0, "09000064804d1a24"], ["FDA-2000-N-0163-0011", "FDA", "FDA-2000-N-0163", "Tab 1 - \"License Revocation Letter to Hollister-Stier Laboratories, LLC, dated August 3, 2000\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice] - Background re: FDA-2000-N-0163-0002", "Supporting & Related Material", "BKG-Background Material", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T14:48:56Z", null, 0, 0, "09000064804d1a1c"], ["FDA-2000-N-0163-0020", "FDA", "FDA-2000-N-0163", "Tab B - \"Delmont Laboratories, Inc.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 229\" - [Covington & Burling [Delmont Laboratories, Inc.] - Supplement Appearance Request] re: FDA-2000-N-0163-0018", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T20:57:04Z", null, 0, 0, "09000064804d1a3d"], ["FDA-2000-N-0163-0018", "FDA", "FDA-2000-N-0163", "Covington & Burling [Delmont Laboratories, Inc.] - Supplement Appearance Request", "Other", "SUP-Supplement", "2009-09-17T04:00:00Z", 2009, 9, "2009-09-17T04:00:00Z", null, "2013-08-11T04:10:38Z", null, 0, 0, "09000064804d1a40"], ["FDA-2000-N-0163-0012", "FDA", "FDA-2000-N-0163", "\"Index of Supporting Documents\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice] - Background re: FDA-2000-N-0163-0002", "Supporting & Related Material", "BKG-Background Material", "2009-09-17T04:00:00Z", 2009, 9, null, null, "2009-09-17T14:49:58Z", null, 0, 0, "09000064804d1a1e"], ["FDA-2000-N-0163-0009", "FDA", "FDA-2000-N-0163", "Tab 3 - \"Letter from Hollister-Stier Laboratories, LLC Surrendering License,\" dated June 19, 2000 - [Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice] - Background re: FDA-2000-N-0163-0002", "Supporting & Related Material", "BKG-Background Material", "2009-09-15T04:00:00Z", 2009, 9, null, null, "2009-09-15T19:53:44Z", null, 0, 0, "09000064804d1a19"], ["FDA-2000-N-0163-0005", "FDA", "FDA-2000-N-0163", "\"Reports for Submission to Docket 00N-1219\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Implementation of Efficacy Review - Notice] - Background re: FDA-2000-N-0163-0001", "Supporting & Related Material", "BKG-Background Material", "2009-09-15T04:00:00Z", 2009, 9, null, null, "2009-09-15T19:37:43Z", null, 0, 0, "09000064804d19e3"], ["FDA-2000-N-0163-0008", "FDA", "FDA-2000-N-0163", "Tab 4 - \"Letter from BioPort Corporation Surrendering License,\" dated August 9, 2000\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice] - Background re: FDA-2000-N-0163-0002", "Supporting & Related Material", "BKG-Background Material", "2009-09-15T04:00:00Z", 2009, 9, null, null, "2009-09-15T19:51:01Z", null, 0, 0, "09000064804d1a17"], ["FDA-2000-N-0163-0006", "FDA", "FDA-2000-N-0163", "Tab 1 - \"Panel on Review of Allergenic Extracts Category IIIA Reclassification, Final Report, December 1983\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Implementation of Efficacy Review - Notice] - Background re: FDA-2000-N-0163-0001", "Supporting & Related Material", "BKG-Background Material", "2009-09-15T04:00:00Z", 2009, 9, null, null, "2009-09-15T19:40:18Z", null, 0, 0, "09000064804d1a04"], ["FDA-2000-N-0163-0007", "FDA", "FDA-2000-N-0163", "Tab 2 - \"Final Report: Addendum to Previous Panel Reports for the Reclassification of Category IIIA Biologics\" - [Biological Products; Bacterial Vaccines and Related Biological Products; Implementation of Efficacy Review - Notice] - Background re: FDA-2000-N-0163-0001", "Supporting & Related Material", "BKG-Background Material", "2009-09-15T04:00:00Z", 2009, 9, null, null, "2009-09-15T19:41:53Z", null, 0, 0, "09000064804d1a06"], ["FDA-2000-N-0163-0004", "FDA", "FDA-2000-N-0163", "Separation of Functions: Delmont Laboratories, Inc.; Opportunity for a Hearing on a Proposal to Revoke U.S. License No. 229 - Memorandum", "Other", "M-Memorandum", "2004-06-08T04:00:00Z", 2004, 6, null, null, "2009-09-11T16:30:09Z", null, 0, 0, "09000064804d1a44"], ["FDA-2000-N-0163-0003", "FDA", "FDA-2000-N-0163", "Delmont Laboratories, Inc.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 229 - Notice of Opportunity of Hearing", "Notice", "NPH-Notice of Opportunity of Hearing", "2003-02-27T05:00:00Z", 2003, 2, "2003-02-27T05:00:00Z", "2003-04-29T03:59:59Z", "2009-09-11T16:25:50Z", null, 0, 0, "09000064804d1a22"], ["FDA-2000-N-0163-0002", "FDA", "FDA-2000-N-0163", "Biological Products; Bacterial Vaccines and Related Biological Products; Revocation of Biologics Licenses - Notice", "Notice", "N-Notice", "2001-05-29T04:00:00Z", 2001, 5, null, null, "2009-09-09T18:32:17Z", null, 0, 0, "09000064804d1a21"], ["FDA-2000-N-0163-0001", "FDA", "FDA-2000-N-0163", "Biological Products; Bacterial Vaccines and Related Biological Products; Implementation of Efficacy Review; Proposed Order - Notice", "Notice", "N-Notice", "2000-05-16T04:00:00Z", 2000, 5, "2000-05-16T04:00:00Z", "2000-08-14T03:59:59Z", "2009-09-09T14:56:32Z", null, 0, 0, "09000064804d19cb"]], "truncated": false, "filtered_table_rows_count": 22, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2000-N-0163"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163", "results": [{"value": "FDA", "label": "FDA", "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2000-N-0163", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163", "results": [{"value": 2009, "label": 2009, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2009", "selected": false}, {"value": 2000, "label": 2000, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2000", "selected": false}, {"value": 2001, "label": 2001, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2001", "selected": false}, {"value": 2003, "label": 2003, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2003", "selected": false}, {"value": 2004, "label": 2004, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2004", "selected": false}, {"value": 2010, "label": 2010, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&posted_year=2010", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2000-N-0163&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 45.98634992726147, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}